Insider Transactions in Q1 2025 at Iovance Biotherapeutics, Inc. (IOVA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 14
2025
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,578
-2.61%
|
$7,890
$5.89 P/Share
|
|
Jan 14
2025
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+4.45%
|
-
|
|
Jan 14
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,578
-2.41%
|
$7,890
$5.89 P/Share
|
|
Jan 14
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+4.12%
|
-
|
|
Jan 14
2025
|
Frederick G Vogt Interim CEO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
9,955
-4.31%
|
$49,775
$5.89 P/Share
|
|
Jan 14
2025
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,835
+8.27%
|
-
|